Detection of Silent Atrial Fibrillation aFter Ischemic StrOke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 317 participants.

Also called NCT02684825

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 317 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02684825
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02684825. Randomized; no masking; primary purpose diagnostic. Start 2015-10 (registry gives no type); primary completion 2022-05-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Detection of Silent Atrial Fibrillation aFter Ischemic StrOke
Acronym
SAFFO
Condition
Cerebral Infarction
Condition
Brain Ischemia
Condition
Brain Infarction
Condition
Cerebrovascular Disorders
Condition
Brain Disease
Condition
Central Nervous System Diseases
Condition
Nervous System Diseases
Condition
Cardiac Arrhythmias
Intervention (Device)
Reveal LINQTM- LNQ11 Internal Loop Recorder plus standard cardiac monitoring
Lead sponsor
Danilo Toni (class: other)
Collaborator
Associazione Italiana Aritmologia e Cardiostimolazione (A.I.A.C.) - Stefano Strano, MD (class: not stated)
Collaborator
Boehringer Ingelheim (class: industry)
Collaborator
Medtronic Italia S.p.A. (class: not stated)
Collaborator
Bayer S.p.A (class: not stated)

Record details

Record id
cardio:ct-nct02684825
Content hash
91af35ce3744bfb2f1da73408df23ed65f3e776fb22a91b8b976bacabaae02a6